Thursday, June 19, 2025, at 6:30pm Quarterly Education & Business Meeting "Choose EPCLUSA for a Proven Chronic Hepatitis C Treatment" (Fleming's Prime Steakhouse)
Flemings Prime Steakhouse and Wine Bar
17400 Haggerty Road
Livonia, MI 48152
Thursday, June 19, 2025 at 6:30pm ET - 9:00pm ET
Add this event to your calendar
Info
Topic
EPCLUSA
Additional Information
You are invited to attend a speaker program. Updated June Invite EPCLUSA (This event is open to members only. Please consider joining GAPNA Membership | Gerontological Advanced Practice Nurses Association (GAPNA) )
EPCLUSA is indicated for the treatment of adults with chronic hepatitis C virus (HCV) genotype 1-6 infection
without cirrhosis or with compensated cirrhosis
DILIP MOONKA, MD
Medical Director, Liver Transplantation
Henry Ford Health System
Speakers
Medical Director, Liver Transplantation
Henry Ford Health System
Dilip Moonka, M.D., Medical Director of the Henry Ford Liver Transplant Program, is an expert in liver transplantation and hepatitis C. As previous director of Henry Ford’s Viral Hepatitis Clinic, he developed unique and highly effective protocols for patients suffering from hepatitis B who are in need of liver transplantation. In addition, as director of clinical research in that division, he published studies on more effective and safer immunosuppressions. Dr. Moonka also has extensive experience in clinical research on hepatitis C with both novel therapies and pegylated interferon. Dr. Moonka earned his medical degree from Stanford University in Palo Alto, California where he also completed a residency in internal medicine. He completed a fellowship in gastroenterology at the University of Pennsylvania in Philadelphia with advanced training in liver disease. He is board certified in internal medicine and gastroenterology.